Inspire Medical Systems (NYSE:INSP) Reaches New 1-Year Low – Should You Sell?

Inspire Medical Systems, Inc. (NYSE:INSP) reached a new 52-week low on Wednesday . The company traded as low as $69.50 and last traded at $68.4250, with a volume of 21556 shares. The stock had previously closed at $72.10.

Analyst Ratings Changes

INSP has been the topic of a number of recent research reports. Mizuho upped their target price on shares of Inspire Medical Systems from $110.00 to $130.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. KeyCorp reissued a “sector weight” rating on shares of Inspire Medical Systems in a research note on Tuesday, November 4th. Stifel Nicolaus set a $110.00 price target on Inspire Medical Systems and gave the company a “buy” rating in a report on Monday, November 24th. Robert W. Baird raised their price objective on Inspire Medical Systems from $125.00 to $180.00 and gave the stock an “outperform” rating in a report on Thursday, December 4th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Inspire Medical Systems in a research report on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Inspire Medical Systems has an average rating of “Hold” and an average target price of $133.47.

Inspire Medical Systems Stock Performance

The firm has a market capitalization of $1.97 billion, a price-to-earnings ratio of 46.01, a P/E/G ratio of 7.41 and a beta of 0.74. The business has a fifty day moving average price of $103.51 and a 200 day moving average price of $94.05.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.53. The business had revenue of $224.50 million for the quarter, compared to analyst estimates of $220.39 million. Inspire Medical Systems had a return on equity of 9.41% and a net margin of 5.05%.The company’s revenue was up 10.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.60 EPS. On average, analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insider Transactions at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 2,000 shares of the stock in a transaction on Friday, November 28th. The shares were sold at an average price of $127.48, for a total value of $254,960.00. Following the completion of the sale, the director owned 26,046 shares of the company’s stock, valued at $3,320,344.08. This represents a 7.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in INSP. Manning & Napier Advisors LLC purchased a new stake in shares of Inspire Medical Systems in the third quarter worth about $32,000. CWM LLC boosted its holdings in Inspire Medical Systems by 216.1% in the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after acquiring an additional 242 shares during the period. V Square Quantitative Management LLC acquired a new stake in Inspire Medical Systems in the fourth quarter valued at approximately $40,000. Larson Financial Group LLC grew its position in Inspire Medical Systems by 21,266.7% in the third quarter. Larson Financial Group LLC now owns 641 shares of the company’s stock valued at $48,000 after acquiring an additional 638 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Inspire Medical Systems during the third quarter valued at approximately $49,000. 94.91% of the stock is owned by hedge funds and other institutional investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.